Synlait Milk reports strong lactoferrin demand
Synlait Milk says there has been strong global demand for its lactoferrin products.
The company began producing and selling the milk protein this year.
It is focused on growth through its infant-formula and nutritionals businesses, and part of that has been the building of a lactoferrin plant.
Synlait is targeting 15 tonnes of spray-dried lactoferrin sales in the financial year to next July 31.
"Our initial focus on its [lactoferrin] application in infant formula and over-the-counter nutraceutical products such as health tablets is paying off," managing director John Penno said.
"Globally, consumers are increasingly looking for nutritious and safe food that contributes to the long-term health and wellbeing of their families. Lactoferrin can help meet these needs."
Lactoferrin is used in the manufacture of infant formula, health food and pharmaceutical products. The bioactive protein provides anti-inflammatory protection and other health benefits.
Customers were looking at lactoferrin as a key ingredient in their infant-formula products, Penno said.
"By producing spray-dried lactoferrin, through a process which has been designed to protect its bioactivity and increase solubility, we are able to meet their needs," he said.
After the upgrade of its specialty milks dryer this year, Synlait became one of two manufacturers in the world able to produce lactoferrin as a spray-dried powder.
The world market for lactoferrin has grown from 45,000 kilograms in 2001 to 185,000kg in 2012. It is projected to grow to 262,000kg in 2017.